Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in uncomplicated influenza
NCT03336619Phase 3Completed
- Sponsor
- Romark Laboratories
- Start
- Jan 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of nitazoxanide in influenza, sponsored by Romark Laboratories. Started Jan 2018; status: completed.
02
Drugs
nitazoxanide
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03336619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336619.